Statins for Prevention of Contrast Induced Nephropathy

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

In this randomized study the investigators wish to explore the role of pre-procedural statin therapy for the prevention of contrast induced nephropathy in patients with moderate-to-severe renal dysfunction, submitted to elective coronary or angioplasty.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ospedale Misericordia e Dolce
• Treatments: Atorvastatin; Atorvastatin Calcium

Criteria

Inclusion Criteria:

• patients with pre-angiographic estimated creatinine clearance < 60 ml/min

Exclusion Criteria:

• contrast medium administration within the previous 10 days

• end-stage renal failure requiring dialysis

• refusal to give informed consent

• previous therapy with statin